A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 38/17 (2006.01) A61K 38/22 (2006.01) A61P 35/00 (2006.01)
Patent
CA 2651263
Urodilatin, a peptide formed in the kidney, has significant anticancer effects, eliminating two thirds of cancer cells within 24 hours Provided are methods for inhibiting the growth of cancer cells comprising contacting a target cancer cell, including a renal carcinoma cell, with urodilatin Further provided are methods for inhibiting the growth of cancer cells comprising contacting a target cancer cell, including a renal carcinoma cell, with a combination of peptide hormones derived from the atrial natriuretic peptide prohormone
La présente concerne l'urodilatine, un peptide formé dans le rein, présentant d'importants effets anti-cancéreux permettant d'éliminer deux-tiers de cellules cancéreuses en 24 heures.
Vesely David L.
Finlayson & Singlehurst
United States Department Of Veterans Affairs
University Of South Florida
LandOfFree
Urodilatin cancer treatment does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Urodilatin cancer treatment, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Urodilatin cancer treatment will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1383180